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It is good that concurrency is becoming a central topic of
discussion in the HIV prevention research community [1].
A healthy debate on this topic is long overdue. A produc-
tive debate requires a solid understanding of the relation-
ship between behavior (at the individual level) and disease
transmission dynamics (at the population level). This
relationship determines the relevant evidence. The con-
cepts are simple, but subtle. Get them wrong, and it is easy
to make some common mistakes, as Lurie and Rosenthal
do here [2].
Lurie and Rosenthal argue that there is not much
empirical support for the concurrency hypothesis. While
they review a great deal of material, much of it is of limited
value, because there is a mismatch between the goal of
assessing concurrency and the methodologies used in the
studies they review. To understand why, we need to back
up a step and ask: Given what we know about how con-
currency inﬂuences transmission, what is the predicted
empirical signature of concurrency’s inﬂuence on the HIV
epidemic?
The short answer is: these dynamics are essentially
driven by network effects, so the empirical signature of
concurrency is not visible using traditional epidemiological
study designs. This is equally true for individual-level and
for population-level designs. So we need to design studies
differently, and we are just beginning to do that. Until this
is done, it is important to avoid some common mistakes.
At the individual level, armed with the traditional epi-
demiological approach to relative risk analysis, one might
expect to ﬁnd that concurrency would increase a person’s
risk of infection, as Lurie and Rosenthal argue in their
discussion of the ﬁndings from Mattson et al., under the
section on ‘‘Empirical Evidence’’. This is the ﬁrst common
mistake. Concurrency is not a risk for the person who has
concurrent partners, it is a risk for that person’s partners.
One way to see this is to consider an initially concordant
negative couple, where one of the partners forms a con-
current partnership. The monogamous partner is now
exposed to the possibility of disease transmission, not by
his/her own behavior, but by the partner’s concurrency. For
the non-monogamous partner, the risk comes simply from
having multiple partners—whether these partners are serial
or concurrent is irrelevant, ceteris paribus. Put another
way, concurrency increases your risk of transmitting
infection, not acquiring it. So the empirical signature is not
the correlation between Person A’s behavior and status, but
between Person A’s behavior and their partner’s status.
Studies that test the association between an individual’s
concurrency and infection status are theoretically mis-
guided and empirically irrelevant.
A detailed discussion of this issue was published nearly
a decade ago, [3] but the issue continues to generate a
remarkable amount of confusion in the literature. Papers
are routinely published with analyses that use logistic
regression to test the signiﬁcance of a person’s concurrency
on their own HIV/STI status, and they are cited in the Lurie
and Rosenthal comment as empirical evidence that con-
currency does not have the predicted effects. The standard
approach to relative risk analysis, and the strong tendency
towards individualistic reductionism in behavioral
research, is so ingrained that this way of thinking is very
difﬁcult to change.
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demiological approach to ecological analysis, one might
expect to ﬁnd that the prevalence of concurrency in a
region would be correlated to the prevalence of HIV, as
Lurie and Rosenthal argue in their discussion of the ﬁnd-
ings from Lagarde et al. [5], under the section on
‘‘Empirical Evidence’’. This is the second common mis-
take. HIV prevalence is a cumulative measure over time—
it represents infections that have accumulated over many
years. Concurrency measures on a survey, by contrast, are
time-delimited, typically for the last year. The predicted
empirical signature of a positive correlation between the
two will only be present when both HIV prevalence and
behavior have been at equilibrium for some time. That is
not the case in any sub-Saharan African country.
This issue, too, was identiﬁed in the literature nearly a
decade ago, [4] in response to the same Lagarde et al. study
that Lurie and Rosenthal cite as support [5]. In contrast to
the logic governing individual level effects, which is
somewhat subtle, the mismatch between cumulative HIV
prevalence and current sexual behavior is fairly obvious.
Still, it remains difﬁcult to establish this standard of evi-
dence in the literature.
What does this mean for empirical research on concur-
rency? It means we need to design studies differently. For
an assessment of the impact of concurrency on individual
level risk, it means one would need to enroll partners into a
study. Ideally, this would be a prospective longitudinal
study of incident infection among couples concordant
negative at enrollment. The practical and ethical difﬁculties
of such a study are clear, though there have been some
valuable public health studies that have sought to follow a
chain of transmission (see below). For an assessment of the
impact of concurrency on population level risk, HIV inci-
dence needs to be the measured endpoint, not HIV preva-
lence, with a matching time window for concurrency. This
requires a longitudinal community-level design with (con-
trolled or natural) variation in the incidence of concurrency,
ideally, an experimental trial that reduced concurrency in an
intervention arm. This is a worthwhile endeavor, and for-
mative research has begun in this direction.
In the meantime, there is empirical evidence at the
individual level that supports the hypothesis that concur-
rency increases the transmission of sexually transmitted
infections, and that it plays an important role in hetero-
sexual transmission in Africa. Two studies using public
health contact tracing data in the US, one on Syphilis [6]
the other on Chlamydia, [7] followed up partners and were
able to estimate the relative odds of transmitting infection
for persons with concurrent partners. Both found that
concurrency increased the odds of transmission by more
than a factor of three. Partner tracing may not be able to
provide the same type of evidence for HIV and
concurrency, since the analysis used in these two papers
requires identifying the direction of transmission, and that
may be hard to establish for prevalent HIV cases. But a
2004 study in Uganda using the BED assay found that
among married persons identiﬁed as incident cases, 51%
had an infected spouse, while 49% did not [8]. That implies
that about half of the incident cases among married persons
may be due to concurrent partnerships. Some fraction of
these newly discordant couples will go onto become con-
cordant positive through spousal transmission (as the other
51% indicates). So the fraction of transmission attributable
to concurrency, directly and indirectly, will be higher than
49%.
This kind of partner enrollment is not a feasible option
for routine epidemiological studies and surveillance. So if
we wish to use more practical traditional survey sampling
designs to examine the impact of concurrency at the indi-
vidual level, there is only one option: the data need to be
analyzed using a principled combination of statistical
estimation and simulation. Note that it is not possible to
represent concurrency explicitly in the traditional com-
partmental models used for epidemiological simulation.
This has been the ﬁnal methodological obstacle to studying
the effects of concurrency. What is needed is ‘‘individual
based models,’’ with the ability to represent the speciﬁc
network conﬁgurations that represent concurrency.
The methodology needed to use traditional survey
sampling data to analyze the impact of concurrency is only
now becoming available. Over the last 10 years, our
research group has been working to develop statistical
methods that provide a principled empirical framework for
network epidemiology. These methods are designed to use
cross-sectional, egocentrically sampled sexual network
data to estimate a model for network dynamics, and then
use this model to generate dynamic stochastic complete
network simulations. We are releasing the code in a pub-
licly licensed software package for general use [9; see
http://www.statnet.org]. Using these methods on US-based
data in a recently published paper, we estimate that the
small differences in concurrency by race observed in the
US are enough to triple the racial disparity in epidemic
potential [10]. The underlying contact network we examine
in this study affects the transmission of any STI, including
HIV, suggesting that concurrency provides a parsimonious
explanation for the longstanding racial disparities in the
prevalence of all STIs. The more important implication,
however, is that this disparity in epidemic potential can be
eliminated by a small change—only 5% of the sexually
active population would have to alter behavior, and they
would not need to have fewer partners, just have their
partners serially rather than concurrently. This is the upside
to nonlinear network effects, and we can leverage it for
prevention.
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fact, interpretation and omission that are pointed out by the
other comments on their piece, but their key argument, that
there is no empirical evidence for the impact of concur-
rency, must be recognized for what it is: the result of a
mismatch between the analytic methods used and the
process under study, not an assessment of the hypothesis. It
is a failure of traditional methodology that is well on the
way to being rectiﬁed.
Should we therefore wait, as the authors conclude, for
better data before developing prevention policies around
concurrency? This is the most puzzling of all their asser-
tions. We can argue about whether concurrency is or is not
a key determinant of the generalized epidemics in sub-
Saharan Africa, but no one argues that concurrency is
irrelevant to transmission. There is nothing to lose, and
potentially everything to gain by reducing the prevalence
of concurrency, in sub-Saharan Africa, as well as in other
populations with disproportionately high rates of HIV/STI.
The non-linear nature of connectivity in networks means
that small differences in concurrency can create large dif-
ferences in epidemic potential and thus tremendous
opportunities for prevention. It would be a real tragedy if
the historical limitations of our research methodology, and
the common errors of interpretation that ﬂow from it, were
used to justify a do-nothing policy.
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